3 news items
Japan Pharma Giant Takeda's Anti-Seizure Treatment Flunks In Two Late-Stage Studies
TAK
17 Jun 24
for UN Procurement.
Among the six key secondary endpoints, soticlestat showed clinically meaningful and nominally significant results
Takeda's Dengue Vaccine Gets WHO Approval, Eligible for UN Procurement
SNY
TAK
15 May 24
by WHO.
The prequalification makes it eligible for procurement
Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage Pipeline Development and Core Operating Profit Margin Expansion
TAK
9 May 24
, the company will implement a significant, multi-year efficiency program focused on organizational agility, procurement saving, and capitalizing on its ongoing
- Prev
- 1
- Next